HIMS & HERS HEALTH INC (HIMS) Fundamental Analysis & Valuation

NYSE:HIMS • US4330001060

Current stock price

30.56 USD
+2.41 (+8.56%)
At close:
30.46 USD
-0.1 (-0.33%)
After Hours:

This HIMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. HIMS Profitability Analysis

1.1 Basic Checks

  • HIMS had positive earnings in the past year.
  • In the past year HIMS had a positive cash flow from operations.
  • In multiple years HIMS reported negative net income over the last 5 years.
  • In multiple years HIMS reported negative operating cash flow during the last 5 years.
HIMS Yearly Net Income VS EBIT VS OCF VS FCFHIMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M 300M

1.2 Ratios

  • The Return On Assets of HIMS (5.96%) is better than 80.00% of its industry peers.
  • HIMS's Return On Equity of 23.73% is amongst the best of the industry. HIMS outperforms 92.00% of its industry peers.
  • HIMS has a Return On Invested Capital of 5.49%. This is comparable to the rest of the industry: HIMS outperforms 60.00% of its industry peers.
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROIC 5.49%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
HIMS Yearly ROA, ROE, ROICHIMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • With a decent Profit Margin value of 5.47%, HIMS is doing good in the industry, outperforming 80.00% of the companies in the same industry.
  • HIMS has a Operating Margin of 5.18%. This is in the better half of the industry: HIMS outperforms 63.00% of its industry peers.
  • With an excellent Gross Margin value of 73.83%, HIMS belongs to the best of the industry, outperforming 91.00% of the companies in the same industry.
  • HIMS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
HIMS Yearly Profit, Operating, Gross MarginsHIMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. HIMS Health Analysis

2.1 Basic Checks

  • HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for HIMS has been increased compared to 1 year ago.
  • The number of shares outstanding for HIMS has been increased compared to 5 years ago.
  • HIMS has a worse debt/assets ratio than last year.
HIMS Yearly Shares OutstandingHIMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
HIMS Yearly Total Debt VS Total AssetsHIMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 3.79 indicates that HIMS is not in any danger for bankruptcy at the moment.
  • HIMS's Altman-Z score of 3.79 is fine compared to the rest of the industry. HIMS outperforms 75.00% of its industry peers.
  • The Debt to FCF ratio of HIMS is 16.94, which is on the high side as it means it would take HIMS, 16.94 years of fcf income to pay off all of its debts.
  • HIMS has a worse Debt to FCF ratio (16.94) than 64.00% of its industry peers.
  • A Debt/Equity ratio of 1.80 is on the high side and indicates that HIMS has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.80, HIMS is not doing good in the industry: 71.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Altman-Z 3.79
ROIC/WACC0.62
WACC8.8%
HIMS Yearly LT Debt VS Equity VS FCFHIMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.90 indicates that HIMS should not have too much problems paying its short term obligations.
  • With a decent Current ratio value of 1.90, HIMS is doing good in the industry, outperforming 78.00% of the companies in the same industry.
  • A Quick Ratio of 1.70 indicates that HIMS should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.70, HIMS is doing good in the industry, outperforming 71.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.9
Quick Ratio 1.7
HIMS Yearly Current Assets VS Current LiabilitesHIMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. HIMS Growth Analysis

3.1 Past

  • The earnings per share for HIMS have decreased by -5.56% in the last year.
  • HIMS shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.00%.
  • The Revenue has been growing by 64.55% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 50.73% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 14.53% on average over the next years. This is quite good.
EPS Next Y14%
EPS Next 2Y11.95%
EPS Next 3Y33.46%
EPS Next 5Y50.73%
Revenue Next Year17.4%
Revenue Next 2Y18.31%
Revenue Next 3Y17.66%
Revenue Next 5Y14.53%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
HIMS Yearly Revenue VS EstimatesHIMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B 4B 5B
HIMS Yearly EPS VS EstimatesHIMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. HIMS Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 59.92, the valuation of HIMS can be described as expensive.
  • HIMS's Price/Earnings ratio is in line with the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.42, HIMS is valued quite expensively.
  • With a Price/Forward Earnings ratio of 52.56, HIMS can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as HIMS.
  • HIMS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.24.
Industry RankSector Rank
PE 59.92
Fwd PE 52.56
HIMS Price Earnings VS Forward Price EarningsHIMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, HIMS is valued a bit more expensive than the industry average as 60.00% of the companies are valued more cheaply.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS indicates a slightly more expensive valuation: HIMS is more expensive than 61.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 121.32
EV/EBITDA 36.68
HIMS Per share dataHIMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as HIMS's earnings are expected to grow with 33.46% in the coming years.
PEG (NY)4.28
PEG (5Y)N/A
EPS Next 2Y11.95%
EPS Next 3Y33.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. HIMS Dividend Analysis

5.1 Amount

  • HIMS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

HIMS Fundamentals: All Metrics, Ratios and Statistics

HIMS & HERS HEALTH INC

NYSE:HIMS (4/24/2026, 8:04:00 PM)

After market: 30.46 -0.1 (-0.33%)

30.56

+2.41 (+8.56%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23
Earnings (Next)05-11
Inst Owners85.5%
Inst Owner Change-0.27%
Ins Owners5.53%
Ins Owner Change14.61%
Market Cap6.97B
Revenue(TTM)2.35B
Net Income(TTM)128.37M
Analysts70
Price Target25.34 (-17.08%)
Short Float %34.53%
Short Ratio1.84
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.8%
Min EPS beat(2)-43.53%
Max EPS beat(2)71.14%
EPS beat(4)3
Avg EPS beat(4)25.02%
Min EPS beat(4)-43.53%
Max EPS beat(4)71.14%
EPS beat(8)7
Avg EPS beat(8)139.72%
EPS beat(12)10
Avg EPS beat(12)110.2%
EPS beat(16)13
Avg EPS beat(16)84.74%
Revenue beat(2)1
Avg Revenue beat(2)-0.49%
Min Revenue beat(2)-2.18%
Max Revenue beat(2)1.2%
Revenue beat(4)2
Avg Revenue beat(4)0.65%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.24%
Revenue beat(12)8
Avg Revenue beat(12)1.06%
Revenue beat(16)12
Avg Revenue beat(16)2.47%
PT rev (1m)-15.55%
PT rev (3m)-43.02%
EPS NQ rev (1m)-31.43%
EPS NQ rev (3m)-84.69%
EPS NY rev (1m)6.46%
EPS NY rev (3m)-2.98%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-5.39%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 59.92
Fwd PE 52.56
P/S 2.97
P/FCF 121.32
P/OCF 23.22
P/B 12.88
P/tB 104.77
EV/EBITDA 36.68
EPS(TTM)0.51
EY1.67%
EPS(NY)0.58
Fwd EY1.9%
FCF(TTM)0.25
FCFY0.82%
OCF(TTM)1.32
OCFY4.31%
SpS10.3
BVpS2.37
TBVpS0.29
PEG (NY)4.28
PEG (5Y)N/A
Graham Number5.21838 (-82.92%)
Profitability
Industry RankSector Rank
ROA 5.96%
ROE 23.73%
ROCE 6.95%
ROIC 5.49%
ROICexc 8.2%
ROICexgc 13.77%
OM 5.18%
PM (TTM) 5.47%
GM 73.83%
FCFM 2.45%
ROA(3y)6.14%
ROA(5y)-5.02%
ROE(3y)14.44%
ROE(5y)-1.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.63%
GM growth 5YN/A
F-Score5
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 16.94
Debt/EBITDA 5.52
Cap/Depr 445.11%
Cap/Sales 10.33%
Interest Coverage 250
Cash Conversion 170.27%
Profit Quality 44.73%
Current Ratio 1.9
Quick Ratio 1.7
Altman-Z 3.79
F-Score5
WACC8.8%
ROIC/WACC0.62
Cap/Depr(3y)344.08%
Cap/Depr(5y)250.41%
Cap/Sales(3y)5.65%
Cap/Sales(5y)4.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-27.27%
EPS Next Y14%
EPS Next 2Y11.95%
EPS Next 3Y33.46%
EPS Next 5Y50.73%
Revenue 1Y (TTM)59%
Revenue growth 3Y64.55%
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year17.4%
Revenue Next 2Y18.31%
Revenue Next 3Y17.66%
Revenue Next 5Y14.53%
EBIT growth 1Y78.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year193.02%
EBIT Next 3Y66.22%
EBIT Next 5Y47.66%
FCF growth 1Y-71.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.48%
OCF growth 3YN/A
OCF growth 5YN/A

HIMS & HERS HEALTH INC / HIMS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HIMS.


What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?

ChartMill assigns a valuation rating of 1 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.


How profitable is HIMS & HERS HEALTH INC (HIMS) stock?

HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 4 / 10.


How financially healthy is HIMS & HERS HEALTH INC?

The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.


What is the expected EPS growth for HIMS & HERS HEALTH INC (HIMS) stock?

The Earnings per Share (EPS) of HIMS & HERS HEALTH INC (HIMS) is expected to grow by 14% in the next year.